SCHEMBL30600506

SCHEMBL30600506

COc1c(Cl)cccc1C(=O)n1nc(N)c2ccc(C3CC3)nc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.49
▸ HTT P42858 8/20 0.49
▸ SMN1; SMN2 Q16637 6/20 0.49
▸ TP53 P04637 3/20 0.49
▸ PKM P14618 1/20 0.49
▸ TTR P02766 1/20 0.39
▸ F2 P00734 1/20 0.39
▸ CTDSP1 Q9GZU7 3/20 0.38
▸ DUSP3 P51452 1/20 0.38
▸ PTPN5 P54829 1/20 0.38
▸ PTPN11 Q06124 1/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ POLB P06746 4/20 0.37
▸ CACNA1B Q00975 2/20 0.37
▸ APBA1 Q02410 2/20 0.37
▸ ELANE P08246 1/20 0.36
▸ LMNA P02545 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26675313 1.00 MAPT (0.49) MAPTHTTSMN1; SMN2TP53PKM
SCHEMBL26908764 0.92 MAPT (0.43) MAPTHTTSMN1; SMN2TP53PKM
SCHEMBL26675311 0.90 MAPT (0.42) MAPTHTTSMN1; SMN2TP53PKM
SCHEMBL30600513 0.90 MAPT (0.42) MAPTHTTSMN1; SMN2TP53PKM
SCHEMBL29767947 0.88 HTT (0.42) MAPTHTTSMN1; SMN2TP53PKM
SCHEMBL26675364 0.88 HTT (0.42) MAPTHTTSMN1; SMN2TP53PKM
SCHEMBL30600516 0.86 MAPT (0.39) MAPTHTTSMN1; SMN2TP53PKM
SCHEMBL26675334 0.86 MAPT (0.39) MAPTHTTSMN1; SMN2TP53PKM
SCHEMBL26675432 0.84 ALOX15 (0.48) MAPTHTTSMN1; SMN2TP53PKM
SCHEMBL30600510 0.81 ELANE (0.44) MAPTHTTSMN1; SMN2TP53PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116867782-A Pyrazole amide derivative 豪夫迈·罗氏有限公司 2023-10-10 — — CN claimed
US-12630549-B2 Pyrazoleamide derivatives HOFFMANN-LA ROCHE INC. (US) 2026-05-19 — — US disclosed
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-11-30 — — US disclosed
CN-116867782-A Pyrazole amide derivative 豪夫迈·罗氏有限公司 2023-10-10 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES P2RY1, P2RX1, P2RX5 MAPT 3058/4885HTT 4269/4885SMN1; SMN2 4421/4885
US-12630549-B2 Pyrazoleamide derivatives CYP11B2, CYP11B1, ADRA1B MAPT 2409/4885HTT 3987/4885SMN1; SMN2 2210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback